Metraipolis › archive › dc_675f4e9108ce
Clinical considerations for the treatment of patients with familial chylomicronemia syndrome using a hepatic-targeted APOC3 antisense oligonucleotide — Europe PMC PMID:41378317
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41378317
- DOI
- 10.1016/j.ajpc.2025.101352
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T13:01:24.329Z
- SHA-256 of the archived text
8dafc096d2cd856fbde1556ae19a61e3dfaf01f42e72d3114694cfb1335118c6- Stable URL of this page
https://metraipolis.com/documento/dc_675f4e9108ce
How to cite
Clinical considerations for the treatment of patients with familial chylomicronemia syndrome using a hepatic-targeted APOC3 antisense oligonucleotide — Europe PMC PMID:41378317 — Europe PMC (en), https://europepmc.org/article/MED/41378317 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_675f4e9108ce (Metraipolis archive dc_675f4e9108ce, sha256 8dafc096d2cd856fbde1556ae19a61e3dfaf01f42e72d3114694cfb1335118c6)
BibTeX
@misc{dc675f4e9108ce,
title = {Clinical considerations for the treatment of patients with familial chylomicronemia syndrome using a hepatic-targeted APOC3 antisense oligonucleotide — Europe PMC PMID:41378317},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41378317},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_675f4e9108ce; sha256 8dafc096d2cd856fbde1556ae19a61e3dfaf01f42e72d3114694cfb1335118c6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41378317. Agents can read the archived copy with the MCP tool read_document.